CD274 and cancer: The best-described strategies to de-activate T-cells are the binding of PD-1 on T-cells to programmed death-ligand 1 (PD-L1) on cancer cells and APCs [65] and CTLA-4 on T-cells to CD80/86 on APCs [66].